首页 > 最新文献

Indo Global Journal of Pharmaceutical Sciences最新文献

英文 中文
Cardio-Protective Effect of Allicin in the Treatment of Hypertension: Home to Medicine 大蒜素治疗高血压的心脏保护作用:医学之家
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.92s13
B. K. Yadav, Gopal L. Khatik
: Allicin (Allium sativum) the most commonly used food constituents is when chopped or crushed release allin in the presence of enzymes Allinase, by losing one molecule of water and forms an active chemical constituent, Allicin. It acts as ACE inhibitor by relaxing the endothelial cells of the heart through release of nitrous oxide formation and finally decreases the peripheral resistance of heart result anti-hypertensive effect. It also reduces the oxidative stress level in hypertensive rats which also proves that it has as anti-hypertensive activity. It has various other mechanisms that reduces hypertension in humans. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite Khatik, Cardio-protective effect of allicin in the treatment of hypertension: home to medicine. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 115.
大蒜素(Allium sativum)最常用的食品成分是当切碎或压碎时,在蒜氨酸酶存在的情况下释放蒜素,通过失去一个水分子而形成一种活性化学成分,蒜素。它通过释放一氧化氮生成物,使心脏内皮细胞松弛,起到ACE抑制剂的作用,最终降低心脏外周阻力,达到降压的作用。它还能降低高血压大鼠的氧化应激水平,这也证明了它具有抗高血压的活性。它有多种其他机制可以降低人类的高血压。©2019 igglobal研究与出版基金会。版权所有。引用哈提克,大蒜素在高血压治疗中的心脏保护作用:家药。印度国际制药公司。科学。, 2019;9(2生理):115。
{"title":"Cardio-Protective Effect of Allicin in the Treatment of Hypertension: Home to Medicine","authors":"B. K. Yadav, Gopal L. Khatik","doi":"10.35652/igjps.2019.92s13","DOIUrl":"https://doi.org/10.35652/igjps.2019.92s13","url":null,"abstract":": Allicin (Allium sativum) the most commonly used food constituents is when chopped or crushed release allin in the presence of enzymes Allinase, by losing one molecule of water and forms an active chemical constituent, Allicin. It acts as ACE inhibitor by relaxing the endothelial cells of the heart through release of nitrous oxide formation and finally decreases the peripheral resistance of heart result anti-hypertensive effect. It also reduces the oxidative stress level in hypertensive rats which also proves that it has as anti-hypertensive activity. It has various other mechanisms that reduces hypertension in humans. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite Khatik, Cardio-protective effect of allicin in the treatment of hypertension: home to medicine. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 115.","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77439460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Herbal Formulations in the Treatment of Helmintheasis 中药制剂在治疗寄生虫病中的作用
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.92s22
Amit Sharma, S. Singh, M. Golati
{"title":"Role of Herbal Formulations in the Treatment of Helmintheasis","authors":"Amit Sharma, S. Singh, M. Golati","doi":"10.35652/igjps.2019.92s22","DOIUrl":"https://doi.org/10.35652/igjps.2019.92s22","url":null,"abstract":"","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85748829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of Neuropathic Pain: A Synergy of NSAIDs & Antidepressant 神经性疼痛的治疗:非甾体抗炎药和抗抑郁药的协同作用
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.92s01
Shubham Kumar, Bhuban Subedi, S. Choudhury, Shubham Sharma, Indu Melkani, B. Kumar
{"title":"Treatment of Neuropathic Pain: A Synergy of NSAIDs & Antidepressant","authors":"Shubham Kumar, Bhuban Subedi, S. Choudhury, Shubham Sharma, Indu Melkani, B. Kumar","doi":"10.35652/igjps.2019.92s01","DOIUrl":"https://doi.org/10.35652/igjps.2019.92s01","url":null,"abstract":"","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"47 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81076220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survey of Medicinally Important Weeds of Daund Tahsil from Pune District (M.S.), India 印度浦那地区药用杂草的调查
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.9203
B. J.G.
{"title":"Survey of Medicinally Important Weeds of Daund Tahsil from Pune District (M.S.), India","authors":"B. J.G.","doi":"10.35652/igjps.2019.9203","DOIUrl":"https://doi.org/10.35652/igjps.2019.9203","url":null,"abstract":"","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"34 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85275068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent Advancements in the Treatment of Rheumatoid Arthritis- A Review 类风湿关节炎治疗的最新进展综述
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.92s26
Lovepreet Kaur, Pooja Sharma, Dinesh Kumar
Rheumatoid arthritis (RA) is an autoimmune disorder affects the joint inflammation due to synovial proliferation and damage of the articular cartilage in the joints. According to the WHO report (2017), 1.3 million people suffer with RA worldwide. Immunosuppressants, 5-amino salicylic acids, TNF – alpha inhibitors, Interleukin -1 antagonists, and corticosteroids are treatment approaches to decrease the severity of the disease. Therapies for rheumatoid arthritis (RA) continue to increases promptly. These traditional treatment methodologies only produce symptomatic relief and are not capable to cure the disease. The purpose of this article is to discuss new treatment options, containing biosimilars, as well as novel agents inhibiting IL-6 and Janus kinase. Sarilumab is the latest biologic for the treatment of RA, approved by the U.S. Food and Drug Administration (FDA) in 2017. It is a human monoclonal antibody consuming higher affinity for the alpha subunit of the interleukin6 (IL-6) receptor. Other drugs that are presently being studied include the IL-6 cytokine blocker sarikumab, the small targeted molecule filgotinib, and many new biosimilars. New non-biologic DMARDs such as PI3Ks inhibitors Phosphoinositide 3-kinases, MMPs inhibitors, matrix metalloproteinases, Glycosidase inhibitors and cathepsin inhibitors are the other novel treatment methods used in the RA. With the discovery of new pathways and therapeutic targets, prospective novel and targeted therapeutic agents are developed that demonstrates their better efficacy in the treatment of RA. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Kaur, L.; Sharma, P.; Kumar, D. Recent Advancements in the Treatment of Rheumatoid ArthritisA Review. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 128. DOI: http://doi.org/10.35652/IGJPS.2019.92S26 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.
类风湿性关节炎(RA)是一种自身免疫性疾病,由于关节滑膜增生和关节软骨损伤而影响关节炎症。根据世界卫生组织(2017年)的报告,全世界有130万人患有类风湿性关节炎。免疫抑制剂、5-氨基水杨酸、TNF - α抑制剂、白细胞介素-1拮抗剂和皮质类固醇是降低疾病严重程度的治疗方法。类风湿性关节炎(RA)的治疗方法继续迅速增加。这些传统的治疗方法只能产生症状缓解,不能治愈疾病。本文的目的是讨论新的治疗方案,包括生物仿制药,以及抑制IL-6和Janus激酶的新药物。Sarilumab是治疗类风湿性关节炎的最新生物制剂,于2017年获得美国食品和药物管理局(FDA)批准。它是一种人单克隆抗体,对白细胞介素6 (IL-6)受体α亚基具有较高的亲和力。目前正在研究的其他药物包括IL-6细胞因子阻滞剂sarikumab,小靶向分子filgotinib和许多新的生物仿制药。新的非生物dmard,如pi3k抑制剂磷酸肌肽3激酶,MMPs抑制剂,基质金属蛋白酶,糖苷酶抑制剂和组织蛋白酶抑制剂是用于RA的其他新治疗方法。随着新的途径和治疗靶点的发现,前瞻性的新型靶向治疗药物被开发出来,在治疗RA方面表现出更好的疗效。©2019 igglobal研究与出版基金会。版权所有。引用本文为:Kaur, L.;沙玛,p;类风湿关节炎治疗的最新进展综述。印度国际制药公司。科学。, 2019;9(2生理):128。DOI: http://doi.org/10.35652/IGJPS.2019.92S26。印度全球药物科学杂志(ISSN 2249 1023;CODENIGJPAI;NLM ID: 101610675)在CrossRef (DOI Enabling), UGC CARE期刊列表,EMBASE(爱思唯尔),国家医学图书馆(NLM)目录,ResearchGate, Publons, CAS (ACS), Index Copernicus,谷歌Scholar等中索引和摘要。欲了解更多详情,请访问http://iglobaljournal.com这是由APTI赞助,印度旁遮普阿姆利则马纳瓦拉斯里赛药学院组织的“RAPSCON-2019”的特刊。以日志形式提供放松。
{"title":"Recent Advancements in the Treatment of Rheumatoid Arthritis- A Review","authors":"Lovepreet Kaur, Pooja Sharma, Dinesh Kumar","doi":"10.35652/igjps.2019.92s26","DOIUrl":"https://doi.org/10.35652/igjps.2019.92s26","url":null,"abstract":"Rheumatoid arthritis (RA) is an autoimmune disorder affects the joint inflammation due to synovial proliferation and damage of the articular cartilage in the joints. According to the WHO report (2017), 1.3 million people suffer with RA worldwide. Immunosuppressants, 5-amino salicylic acids, TNF – alpha inhibitors, Interleukin -1 antagonists, and corticosteroids are treatment approaches to decrease the severity of the disease. Therapies for rheumatoid arthritis (RA) continue to increases promptly. These traditional treatment methodologies only produce symptomatic relief and are not capable to cure the disease. The purpose of this article is to discuss new treatment options, containing biosimilars, as well as novel agents inhibiting IL-6 and Janus kinase. Sarilumab is the latest biologic for the treatment of RA, approved by the U.S. Food and Drug Administration (FDA) in 2017. It is a human monoclonal antibody consuming higher affinity for the alpha subunit of the interleukin6 (IL-6) receptor. Other drugs that are presently being studied include the IL-6 cytokine blocker sarikumab, the small targeted molecule filgotinib, and many new biosimilars. New non-biologic DMARDs such as PI3Ks inhibitors Phosphoinositide 3-kinases, MMPs inhibitors, matrix metalloproteinases, Glycosidase inhibitors and cathepsin inhibitors are the other novel treatment methods used in the RA. With the discovery of new pathways and therapeutic targets, prospective novel and targeted therapeutic agents are developed that demonstrates their better efficacy in the treatment of RA. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Kaur, L.; Sharma, P.; Kumar, D. Recent Advancements in the Treatment of Rheumatoid ArthritisA Review. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 128. DOI: http://doi.org/10.35652/IGJPS.2019.92S26 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75388743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Synbiotics in Management of Lifestyle Disorders 合生素在生活方式障碍治疗中的作用
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.92s10
R. Khursheed, A. Awasthi, Sheetu Wadhwa, M. Gulati, S. Singh
Gut microflora plays a crucial role in the metabolism of various nutritional substrates for the maintenance of human health. Numerous studies on synbiotics in both non-clinical as well as clinical cases have shown promising results in maintaining the balance of gastrointestinal (GIT) microbiota to improve health conditions. Due to certain conditions such as high fat diet, stress and sedentary lifestyle, bacterial balance may be changed leading to gut dysbiosis and thus manifests in lifestyle disorders such as diabetes, obesity and atherosclerosis. These lifestyle disorders are associated with gut dysbiosis wherein there is increase in gram negative bacteria and decrease in beneficial gram-positive bacteria. The increased level of gram negative bacteria causes increase in lipopolysacharrides (LPS), endotoxemia, diabetes, dyslipidaemia and obesity. It is seen that individuals with increased adiposity and dyslipidaemia are characterized by increased levels of LPS. Synbiotics’ administration decreases these LPS and thus decreases inflammation, insulin resistance, diabetes, adiposity and obesity. Synbiotics are also known to influence apetite as well as food intake thereby, treat obesity. Synbiotics manage dyslipidaemia by decreasing cholesterol through inhibiting its intestinal absorption, increasing its excretion and supressing the bile acid reabsorption. The current presentation highlights the role of synbiotics in management of lifestyle disorders and various marketed products containing them. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Khursheed, R.; Awasthi, A.; Wadhwa, S.; Gulati, M.; Singh, S.K. Role of synbiotics in Management of Lifestyle Disorders. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 112. DOI: http://doi.org/10.35652/IGJPS.2019.92S10 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.
肠道菌群在维持人体健康的各种营养基质代谢中起着至关重要的作用。在非临床和临床病例中对合生剂的大量研究表明,合生剂在维持胃肠道微生物群平衡以改善健康状况方面具有良好的效果。由于某些条件,如高脂肪饮食、压力和久坐不动的生活方式,细菌平衡可能会改变,导致肠道生态失调,从而表现为生活方式紊乱,如糖尿病、肥胖和动脉粥样硬化。这些生活方式紊乱与肠道生态失调有关,其中革兰氏阴性菌增加,有益的革兰氏阳性菌减少。革兰氏阴性菌水平的增加导致脂多糖(LPS)、内毒素血症、糖尿病、血脂异常和肥胖的增加。可见,肥胖和血脂异常的个体以脂多糖水平升高为特征。合成制剂可以减少这些脂多糖,从而减少炎症、胰岛素抵抗、糖尿病、肥胖和肥胖。人们还知道,合成抗生素可以影响食欲和食物摄入量,从而治疗肥胖。合成抗生素通过抑制胆固醇的肠道吸收、增加其排泄和抑制胆汁酸的再吸收来降低胆固醇,从而控制血脂异常。目前的报告强调了合生素在生活方式疾病管理中的作用以及含有它们的各种市场产品。©2019 igglobal研究与出版基金会。版权所有。引用本文如下:Khursheed, R.;Awasthi, a;Wadhwa,美国;Gulati m;合生素在生活方式障碍管理中的作用。印度国际制药公司。科学。, 2019;9(2生理):112。DOI: http://doi.org/10.35652/IGJPS.2019.92S10。印度全球药物科学杂志(ISSN 2249 1023;CODENIGJPAI;NLM ID: 101610675)在CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index哥白尼,Google Scholar等中索引和摘要。欲了解更多详情,请访问http://iglobaljournal.com这是由APTI赞助,印度旁遮普阿姆利则马纳瓦拉斯里赛药学院组织的“RAPSCON-2019”的特刊。以日志形式提供放松。
{"title":"Role of Synbiotics in Management of Lifestyle Disorders","authors":"R. Khursheed, A. Awasthi, Sheetu Wadhwa, M. Gulati, S. Singh","doi":"10.35652/igjps.2019.92s10","DOIUrl":"https://doi.org/10.35652/igjps.2019.92s10","url":null,"abstract":"Gut microflora plays a crucial role in the metabolism of various nutritional substrates for the maintenance of human health. Numerous studies on synbiotics in both non-clinical as well as clinical cases have shown promising results in maintaining the balance of gastrointestinal (GIT) microbiota to improve health conditions. Due to certain conditions such as high fat diet, stress and sedentary lifestyle, bacterial balance may be changed leading to gut dysbiosis and thus manifests in lifestyle disorders such as diabetes, obesity and atherosclerosis. These lifestyle disorders are associated with gut dysbiosis wherein there is increase in gram negative bacteria and decrease in beneficial gram-positive bacteria. The increased level of gram negative bacteria causes increase in lipopolysacharrides (LPS), endotoxemia, diabetes, dyslipidaemia and obesity. It is seen that individuals with increased adiposity and dyslipidaemia are characterized by increased levels of LPS. Synbiotics’ administration decreases these LPS and thus decreases inflammation, insulin resistance, diabetes, adiposity and obesity. Synbiotics are also known to influence apetite as well as food intake thereby, treat obesity. Synbiotics manage dyslipidaemia by decreasing cholesterol through inhibiting its intestinal absorption, increasing its excretion and supressing the bile acid reabsorption. The current presentation highlights the role of synbiotics in management of lifestyle disorders and various marketed products containing them. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Khursheed, R.; Awasthi, A.; Wadhwa, S.; Gulati, M.; Singh, S.K. Role of synbiotics in Management of Lifestyle Disorders. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 112. DOI: http://doi.org/10.35652/IGJPS.2019.92S10 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73799106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent Advancements in the Treatment of Anxiety by Natural Drugs 天然药物治疗焦虑的最新进展
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.92s29
Nikhi Sharma, Pooja Sharma, Dinesh Kumar
: Anxiety affects about total of one-eighth individuals worldwide and has become an essential field of research in psychopharmacology. It is estimated that more than 10 million populations are suffering from anxiety every year in India. Anxiety, which is a state of extreme fear and is characterized by the sympathetic hyperactivity, vigilance syndromes, motor tension and apprehension. Several anti-anxiety drugs have been used for the treatment of anxiety. Benzodiazepens are the most important category of compounds that have been used for treating anxiety, but the long term utilization of these drugs may produce physiological and psychological dependence. Furthermore, the drugs used for anxiety can cause serious adverse effects such as sleep disturbances, cholinergic symptoms, blurred vision, weight gain, gastrointestinal problems, sexual dysfunction and medication dependence. Hence, herbal medicinal plants are used for the treatment of anxiety because of their potent therapeutic activities and lesser side effects as compare to the usual anti-anxiety drugs. Some traditional plants that are used as anxiolytics are Valeriana officinalis, Tilia europeae, Chenopodium ambrosioides and Passiflora coerulea . Valerenic acid that is obtained from Valeriana officinalis , acts with the GABA-nergic system to treat anxiety. Further, more natural drugs should be invented and researched for obtaining wide range of applications. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Sharma, N.; Sharma, P.; Kumar, D. Recent Advancements
焦虑影响着全世界大约八分之一的人,它已经成为精神药理学的一个重要研究领域。据估计,印度每年有超过1000万人患有焦虑症。焦虑,这是一种极度恐惧的状态,以交感神经过度活跃、警惕综合征、运动紧张和恐惧为特征。几种抗焦虑药物已被用于治疗焦虑。苯二氮卓类药物是用于治疗焦虑的最重要的一类化合物,但长期使用这些药物可能产生生理和心理依赖。此外,用于焦虑的药物会引起严重的副作用,如睡眠障碍、胆碱能症状、视力模糊、体重增加、胃肠道问题、性功能障碍和药物依赖。因此,草药植物被用于治疗焦虑,因为它们具有有效的治疗活性,而且与通常的抗焦虑药物相比,副作用更小。一些用作抗焦虑药的传统植物是缬草、欧洲椴、藜草和西番莲。从缬草中提取的戊烯酸与gaba -能系统一起作用来治疗焦虑。此外,应该发明和研究更多的天然药物,以获得广泛的应用。©2019 igglobal研究与出版基金会。版权所有。引用本文如下:Sharma, N.;沙玛,p;库马尔,D.最近的进展
{"title":"Recent Advancements in the Treatment of Anxiety by Natural Drugs","authors":"Nikhi Sharma, Pooja Sharma, Dinesh Kumar","doi":"10.35652/igjps.2019.92s29","DOIUrl":"https://doi.org/10.35652/igjps.2019.92s29","url":null,"abstract":": Anxiety affects about total of one-eighth individuals worldwide and has become an essential field of research in psychopharmacology. It is estimated that more than 10 million populations are suffering from anxiety every year in India. Anxiety, which is a state of extreme fear and is characterized by the sympathetic hyperactivity, vigilance syndromes, motor tension and apprehension. Several anti-anxiety drugs have been used for the treatment of anxiety. Benzodiazepens are the most important category of compounds that have been used for treating anxiety, but the long term utilization of these drugs may produce physiological and psychological dependence. Furthermore, the drugs used for anxiety can cause serious adverse effects such as sleep disturbances, cholinergic symptoms, blurred vision, weight gain, gastrointestinal problems, sexual dysfunction and medication dependence. Hence, herbal medicinal plants are used for the treatment of anxiety because of their potent therapeutic activities and lesser side effects as compare to the usual anti-anxiety drugs. Some traditional plants that are used as anxiolytics are Valeriana officinalis, Tilia europeae, Chenopodium ambrosioides and Passiflora coerulea . Valerenic acid that is obtained from Valeriana officinalis , acts with the GABA-nergic system to treat anxiety. Further, more natural drugs should be invented and researched for obtaining wide range of applications. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Sharma, N.; Sharma, P.; Kumar, D. Recent Advancements","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"22 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73337651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Overview of Capsiate in Management of Hypothermia and Life Style Diseases capapate在低温和生活方式疾病治疗中的应用综述
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.92s09
A. Awasthi, R. Khursheed, M. Gulati, S. Singh
Capsiate is an important non-pungent phytoconstituent which is obtained from the fruits of plant Capsicum annuum. Due to non-pungency, capsiate is used in food items instead of capsaicin. The reason of capsiate non-pungency is due to its expeditious hydrolysation in the presence of aqueous conditions, which leads to decrease in its approachability towards nociceptors e.g., in the oral cavity. Capsiate consists of ester linkage between fatty acid chain and the vanillyl group while capsaicin consists of amide linkage between the vanillyl group and the fatty acid chain. On metabolism capsiate gets biotransformed and decomposed into vanillyl alchol, vanillic acid and glucuronide conjugates. Capsiate is a novel pharmacotherapeutic which helps in the management of various diseases like hypothermia, diabetes and obesity. Capsiate shows different mechanism of action in different diseases. In hypothermia capsiate act on vanilloid receptor subtype transient receptor potential cation channel subfamily V member 1 (TRPV1) and shows thermogenic effect. While in diabetes, capsiate increases the mass of beta cells which leads to increase in proliferation or decrease apoptosis of β cells and further potentiates insulin/insulin like growth factor (IGF-1) signaling. In obesity, capsiate downregulates uncoupling protein 3 (UCP-3) and enhance muscle oxidative capacity and results in decrease of abdominal fat. Through the current presentation an attempt has been made to highlight various pharmacological actions of capsiate. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Awasthi, A.; Khursheed, R.; Gulati, M.; Singh, S.K. An overview of capsiate in management of hypothermia and life style diseases. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 111. DOI: http://doi.org/10.35652/IGJPS.2019.92S09 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.
辣椒素是从辣椒果实中提取的一种重要的非刺激性植物成分。由于不辛辣,辣椒素被用于食品中,而不是辣椒素。胶囊不刺激性的原因是由于其在水条件下迅速水解,这导致其对伤害感受器(例如口腔中的伤害感受器)的接近性降低。辣椒素是由脂肪酸链与香草基之间的酰胺键构成,而辣椒素是由香草基与脂肪酸链之间的酰胺键构成。在代谢过程中,香草酸被生物转化并分解为香草醇、香草酸和葡萄糖醛酸缀合物。Capsiate是一种新型的药物治疗药物,有助于治疗各种疾病,如体温过低、糖尿病和肥胖。capyate在不同疾病中表现出不同的作用机制。在低温下,衣壳酸作用于香草受体亚型瞬时受体电位阳离子通道亚家族成员1 (TRPV1),并表现出产热作用。而在糖尿病中,衣壳酸增加β细胞的质量,导致β细胞增殖增加或凋亡减少,并进一步增强胰岛素/胰岛素样生长因子(IGF-1)信号传导。在肥胖中,衣壳酸下调解偶联蛋白3 (uncoupling protein 3, UCP-3),增强肌肉氧化能力,导致腹部脂肪减少。通过目前的介绍,已经试图强调各种药理学作用的胶囊。©2019 igglobal研究与出版基金会。版权所有。引用本文如下:Awasthi, A.;无独有偶,r;Gulati m;低体温症和生活方式疾病的capapate管理综述。印度国际制药公司。科学。, 2019;9(2生理):111。DOI: http://doi.org/10.35652/IGJPS.2019.92S09。印度全球药物科学杂志(ISSN 2249 1023;CODENIGJPAI;NLM ID: 101610675)在CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index哥白尼,Google Scholar等中索引和摘要。欲了解更多详情,请访问http://iglobaljournal.com这是由APTI赞助,印度旁遮普阿姆利则马纳瓦拉斯里赛药学院组织的“RAPSCON-2019”的特刊。以日志形式提供放松。
{"title":"An Overview of Capsiate in Management of Hypothermia and Life Style Diseases","authors":"A. Awasthi, R. Khursheed, M. Gulati, S. Singh","doi":"10.35652/igjps.2019.92s09","DOIUrl":"https://doi.org/10.35652/igjps.2019.92s09","url":null,"abstract":"Capsiate is an important non-pungent phytoconstituent which is obtained from the fruits of plant Capsicum annuum. Due to non-pungency, capsiate is used in food items instead of capsaicin. The reason of capsiate non-pungency is due to its expeditious hydrolysation in the presence of aqueous conditions, which leads to decrease in its approachability towards nociceptors e.g., in the oral cavity. Capsiate consists of ester linkage between fatty acid chain and the vanillyl group while capsaicin consists of amide linkage between the vanillyl group and the fatty acid chain. On metabolism capsiate gets biotransformed and decomposed into vanillyl alchol, vanillic acid and glucuronide conjugates. Capsiate is a novel pharmacotherapeutic which helps in the management of various diseases like hypothermia, diabetes and obesity. Capsiate shows different mechanism of action in different diseases. In hypothermia capsiate act on vanilloid receptor subtype transient receptor potential cation channel subfamily V member 1 (TRPV1) and shows thermogenic effect. While in diabetes, capsiate increases the mass of beta cells which leads to increase in proliferation or decrease apoptosis of β cells and further potentiates insulin/insulin like growth factor (IGF-1) signaling. In obesity, capsiate downregulates uncoupling protein 3 (UCP-3) and enhance muscle oxidative capacity and results in decrease of abdominal fat. Through the current presentation an attempt has been made to highlight various pharmacological actions of capsiate. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Awasthi, A.; Khursheed, R.; Gulati, M.; Singh, S.K. An overview of capsiate in management of hypothermia and life style diseases. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 111. DOI: http://doi.org/10.35652/IGJPS.2019.92S09 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89550828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alzheimer’s Management 阿尔茨海默氏症的管理
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.92s55
Guramritpal Singh, D. Kumar
{"title":"Alzheimer’s Management","authors":"Guramritpal Singh, D. Kumar","doi":"10.35652/igjps.2019.92s55","DOIUrl":"https://doi.org/10.35652/igjps.2019.92s55","url":null,"abstract":"","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79011234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Software Used for New Drug Discovery and Development 用于新药发现和开发的软件
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.92s03
G. Bawa, N. Khurana
Exploration of model based tools and software used for the development and discovery of new drugs in pharmaceuticals industry, playing a vital role to expand the bioactive drugs. The proper use of software and modern based computers has reduced various hindrances in the drug discovery process. The software used in pharmaceutical industry are categorized as Pharmacokinetic Parameters which include DDDPlus (Dose Dissolution and Disintegration software) to study the dissolution and disintegration of drugs, GastroPlus for the study of In vitro and in vivo correlation for various formulations; Ligand interactions and molecular dynamic such as Schodinger for the study of ligand receptor docking, GOLD (Genetic Optimization for Ligand Docking) to study the protein –ligand docking; Molecular modeling and structural activity relationship, for the study of molecular modeling analysis, prediction of protein-ligand binding affinity, create and analysis of SAR models and molecular docking and calculations and molecular modeling package Maestro, Sanjeevini, PASS() and ArgusLab are used respectively; For the study of Behavioral parameters Ethowatcher for behavioral analysis and MARS (Multimodal Animal Rotation System) to check the enzyme activity, nanoparticle tracking and delivery study followed by Data Analysis QSARPro and REST 2009 Software are used to obtain the data of protein-protein interaction and In vivo imaging display and analysis. The above mentioned softwares provide valuable insights of experimental findings and mechanisms of action. These techniques help in reduction of cost of drug designing and development. In Pharmaceutical industry softwares areexhibiting imperative role in the different phases of drug discovery. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Bawa; G.; Khurana, N. Software used for new drug discovery and development. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 105. DOI: http://doi.org/10.35652/IGJPS.2019.92S03 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.
探索基于模型的工具和软件用于制药行业新药的开发和发现,对扩大生物活性药物起着至关重要的作用。软件和现代计算机的正确使用减少了药物发现过程中的各种障碍。制药行业使用的软件分为药代动力学参数,包括DDDPlus(剂量溶出与崩解软件)用于研究药物的溶出与崩解,GastroPlus用于研究各种配方的体内外相关性;配体相互作用和分子动力学如Schodinger为研究配体与受体对接,GOLD (Genetic Optimization for Ligand docking)为研究蛋白质与配体对接;分子建模和结构活性关系,用于研究分子建模分析,预测蛋白质与配体结合亲和力,创建和分析SAR模型并进行分子对接和计算,分子建模包分别使用Maestro、Sanjeevini、PASS()和ArgusLab;行为学参数研究采用Ethowatcher进行行为学分析,MARS (Multimodal Animal Rotation System)检测酶活性,采用纳米颗粒跟踪和递送研究,采用数据分析软件QSARPro和REST 2009软件获取蛋白质-蛋白质相互作用数据,并进行体内成像显示和分析。上述软件为实验结果和作用机制提供了有价值的见解。这些技术有助于降低药物设计和开发的成本。在制药工业中,软件在药物发现的不同阶段发挥着重要作用。©2019 igglobal研究与出版基金会。版权所有。引用这篇文章为:巴瓦;g;用于新药发现和开发的软件。印度国际制药公司。科学。, 2019;9(2生理):105。DOI: http://doi.org/10.35652/IGJPS.2019.92S03。印度全球药物科学杂志(ISSN 2249 1023;CODENIGJPAI;NLM ID: 101610675)在CrossRef (DOI Enabling), UGC CARE期刊列表,EMBASE(爱思唯尔),国家医学图书馆(NLM)目录,ResearchGate, Publons, CAS (ACS), Index Copernicus,谷歌Scholar等中索引和摘要。欲了解更多详情,请访问http://iglobaljournal.com这是由APTI赞助,印度旁遮普阿姆利则马纳瓦拉斯里赛药学院组织的“RAPSCON-2019”的特刊。以日志形式提供放松。
{"title":"Software Used for New Drug Discovery and Development","authors":"G. Bawa, N. Khurana","doi":"10.35652/igjps.2019.92s03","DOIUrl":"https://doi.org/10.35652/igjps.2019.92s03","url":null,"abstract":"Exploration of model based tools and software used for the development and discovery of new drugs in pharmaceuticals industry, playing a vital role to expand the bioactive drugs. The proper use of software and modern based computers has reduced various hindrances in the drug discovery process. The software used in pharmaceutical industry are categorized as Pharmacokinetic Parameters which include DDDPlus (Dose Dissolution and Disintegration software) to study the dissolution and disintegration of drugs, GastroPlus for the study of In vitro and in vivo correlation for various formulations; Ligand interactions and molecular dynamic such as Schodinger for the study of ligand receptor docking, GOLD (Genetic Optimization for Ligand Docking) to study the protein –ligand docking; Molecular modeling and structural activity relationship, for the study of molecular modeling analysis, prediction of protein-ligand binding affinity, create and analysis of SAR models and molecular docking and calculations and molecular modeling package Maestro, Sanjeevini, PASS() and ArgusLab are used respectively; For the study of Behavioral parameters Ethowatcher for behavioral analysis and MARS (Multimodal Animal Rotation System) to check the enzyme activity, nanoparticle tracking and delivery study followed by Data Analysis QSARPro and REST 2009 Software are used to obtain the data of protein-protein interaction and In vivo imaging display and analysis. The above mentioned softwares provide valuable insights of experimental findings and mechanisms of action. These techniques help in reduction of cost of drug designing and development. In Pharmaceutical industry softwares areexhibiting imperative role in the different phases of drug discovery. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Bawa; G.; Khurana, N. Software used for new drug discovery and development. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 105. DOI: http://doi.org/10.35652/IGJPS.2019.92S03 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72707983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indo Global Journal of Pharmaceutical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1